Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Non-Steroidal Anti-Inflammatory Drug Applied to Skin Lessens Muscle Soreness After Exercise

14.07.2003


Researchers at the University of California, San Diego (UCSD) School of Medicine have shown that a non-steroidal anti-inflammatory drug (NSAID) applied as a cream directly to the skin is safe and effective in lessening muscle soreness experienced 24 to 48 hours following exercise, when soreness reaches its peak. In addition, the direct application bypasses the internal body-route taken by oral medications, thus avoiding unpleasant side effects sometimes experienced with NSAIDs.



In a study published in the July issue of the Clinical Journal of Sport Medicine, the investigators compared a transdermal (cream) version of an NSAID called ketoprofen against a cream version of a placebo, in a study with 32 healthy males between the ages of 18 and 35 years. Women were not included to avoid fertility or pregnancy complications.

At 48 hours following exercise, the study volunteers who used the NSAID cream reported 37 to 45 percent less muscle soreness than those who used a placebo.


Currently, oral NSAIDs are the most commonly prescribed medications for pain relief and reduction of inflammation experienced after exercise. However, individuals experience significant systemic side effects, such as gastrointestinal distress and problems with liver and kidney function. Annually, an estimated 103,000 patients are hospitalized each year in the U.S. for NSAID-induced gastrointestinal complications, and more than 16,000 NSAID-related deaths occur each year among arthritis patients alone.

The research team did not expect side effects with the transdermal application of the NSAID, since only about one percent of medication directly applied to the skin is absorbed systemically. To verify this, the research team obtained blood samples from the participants, so to measure system absorption of ketoprofen, which is an indicator of potential side effects, such as gastrointestinal irritation. Using a liquid chromatography/mass spectrometry method, the investigators found that serum ketoprofen levels at 24 and 48 hours was minimal, even below the normal detection limit of 10 ng/mL.

The paper’s authors noted that "if an effective transdermal method of NSAID delivery were available, these limitations of oral delivery could be avoided. Further, a transdermal delivery system would have the advantage of delivering NSAIDs directly to the desired location."

However, transdermal formulations of NSAIDs are not commercially available in the U.S. Physicians must prescribe a customized, individual compound that is prepared by pharmacists.

The researchers noted that additional studies would be needed to evaluate the efficacy of long-term treatment with transdermal ketoprofen, and the efficacy of the drug in treating chronic inflammatory conditions such as arthritis.

The study was funded by Trans-Pharma Pharmaceutical Co., which makes the transdermal cream version of ketoprofen.

The paper’s senior author was Mark D. Bracker, M.D., a UCSD professor of family and preventive medicine; the first author was Christopher R. Cannavino, M.D., a resident in the UCSD Department of Pediatrics. Additional contributors were Lawrence A. Palinkas, Ph.D., UCSD professor of family and preventive medicine, Anthony Salimbeni, M.D., a former faculty member in the UCSD Department of Family and Preventive Medicine, and Jeffrey Abrams, M.D., MPH, director of product development, Trans-Pharma Pharmaceutical Co.


News Media Contact:
Sue Pondrom
619-543-6163
spondrom@ucsd.edu

Sue Pondrom | UCSD News
Further information:
http://health.ucsd.edu/news/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>